Anne-Laure Voisin

2.6k total citations
19 papers, 892 citations indexed

About

Anne-Laure Voisin is a scholar working on Oncology, Pharmacology and Genetics. According to data from OpenAlex, Anne-Laure Voisin has authored 19 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 4 papers in Pharmacology and 4 papers in Genetics. Recurrent topics in Anne-Laure Voisin's work include Cancer Immunotherapy and Biomarkers (17 papers), Colorectal Cancer Treatments and Studies (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Anne-Laure Voisin is often cited by papers focused on Cancer Immunotherapy and Biomarkers (17 papers), Colorectal Cancer Treatments and Studies (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Anne-Laure Voisin collaborates with scholars based in France, Italy and Switzerland. Anne-Laure Voisin's co-authors include Olivier Lambotte, Jean‐Marie Michot, Stéphane Champiat, Aurélien Marabelle, Salim Laghouati, Christine Mateus, Jean‐Charles Soria, Xavier Mariette, Laetitia Dunogeant and O. Fain and has published in prestigious journals such as Gastroenterology, Annals of Oncology and Annals of the Rheumatic Diseases.

In The Last Decade

Anne-Laure Voisin

19 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne-Laure Voisin France 11 739 171 153 151 122 19 892
Jean Tayar United States 10 453 0.6× 163 1.0× 138 0.9× 185 1.2× 93 0.8× 30 846
Mary Kate Kasler United States 6 620 0.8× 172 1.0× 191 1.2× 48 0.3× 135 1.1× 8 713
B. Rovati Italy 16 318 0.4× 265 1.5× 76 0.5× 54 0.4× 51 0.4× 38 651
Konstantin Schlick Austria 15 255 0.3× 45 0.3× 83 0.5× 78 0.5× 75 0.6× 35 526
Benjamin C. Garden United States 7 290 0.4× 36 0.2× 109 0.7× 44 0.3× 92 0.8× 13 547
Jessica Quarna Italy 12 256 0.3× 59 0.3× 58 0.4× 101 0.7× 59 0.5× 17 577
Anwar Giryes Switzerland 12 374 0.5× 46 0.3× 180 1.2× 45 0.3× 133 1.1× 21 602
Giovanna Motta Italy 15 225 0.3× 187 1.1× 88 0.6× 86 0.6× 56 0.5× 45 621
Gan‐di Li China 13 342 0.5× 141 0.8× 103 0.7× 67 0.4× 46 0.4× 65 641
Hassan El‐Solh Saudi Arabia 15 226 0.3× 86 0.5× 83 0.5× 97 0.6× 40 0.3× 40 693

Countries citing papers authored by Anne-Laure Voisin

Since Specialization
Citations

This map shows the geographic impact of Anne-Laure Voisin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne-Laure Voisin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne-Laure Voisin more than expected).

Fields of papers citing papers by Anne-Laure Voisin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne-Laure Voisin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne-Laure Voisin. The network helps show where Anne-Laure Voisin may publish in the future.

Co-authorship network of co-authors of Anne-Laure Voisin

This figure shows the co-authorship network connecting the top 25 collaborators of Anne-Laure Voisin. A scholar is included among the top collaborators of Anne-Laure Voisin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne-Laure Voisin. Anne-Laure Voisin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kfoury, Maria, Anne-Laure Voisin, Stéphane Champiat, et al.. (2022). Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias. Cancer Treatment Reviews. 110. 102452–102452. 35 indexed citations
2.
Laparra, Ariane, François‐Xavier Danlos, Stéphane Champiat, et al.. (2021). The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry. European Journal of Cancer. 158. 217–224. 58 indexed citations
3.
Laparra, Ariane, Maria Kfoury, Stéphane Champiat, et al.. (2021). Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?. Annals of Oncology. 32(7). 936–937. 5 indexed citations
4.
Baldini, Capucine, P. Martin Romano, Anne-Laure Voisin, et al.. (2020). Impact of aging on immune-related adverse events generated by anti–programmed death (ligand)PD-(L)1 therapies. European Journal of Cancer. 129. 71–79. 63 indexed citations
5.
Karam, J.D., Nicolas Noël, Anne-Laure Voisin, et al.. (2020). Infectious complications in patients treated with immune checkpoint inhibitors. European Journal of Cancer. 141. 137–142. 31 indexed citations
6.
Michot, Jean‐Marie, Julien Lazarovici, Stéphane Champiat, et al.. (2019). Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?. European Journal of Cancer. 122. 72–90. 116 indexed citations
7.
Hans, Sophie, Laurent Dercle, Stéphane Champiat, et al.. (2019). Sarcoidosis-like reaction mimics progression in patients treated with immune checkpoint inhibitors. Annals of Oncology. 30. v529–v530. 2 indexed citations
8.
Babai, Samy, et al.. (2019). Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort Study. Drug Safety. 43(2). 111–117. 19 indexed citations
9.
Michot, Jean‐Marie, Emmanuel Barreau, Olivier Lambotte, et al.. (2019). Prevalence and Clinical Patterns of Ocular Complications Associated With Anti-PD-1/PD-L1 Anticancer Immunotherapy. American Journal of Ophthalmology. 202. 109–117. 65 indexed citations
10.
Michot, Jean‐Marie, Audrey Simonaggio, Rakiba Belkhir, et al.. (2019). The ImmunoTOX multidisciplinary board: A descriptive study of collaborative management of immune-related adverse events. Annals of Oncology. 30. v719–v719. 4 indexed citations
11.
Michot, Jean‐Marie, Thibault Comont, Claude Chahine, et al.. (2018). Cytopénies immunologiques induites par des anticorps anti-PD-1 ou anti-PD-L1 : une étude observationnelle descriptive. La Revue de Médecine Interne. 39. A35–A36. 1 indexed citations
12.
Baldini, Capucine, Patricia Martín-Romano, Anne-Laure Voisin, et al.. (2018). Incidence of immune related adverse events in patients 70 years old treated with anti-PD-(L)1 therapy. Annals of Oncology. 29. viii428–viii429. 4 indexed citations
13.
Kfoury, Maria, Anne-Laure Voisin, Stéphane Champiat, et al.. (2018). Association between immune-related adverse events and efficacy in patients treated with anti-PD-(L)1. Annals of Oncology. 29. viii405–viii405. 7 indexed citations
14.
Collins, Michael, Jean‐Marie Michot, Charlotte Mussini, et al.. (2017). Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies. Annals of Oncology. 28(11). 2860–2865. 124 indexed citations
15.
Belkhir, Rakiba, S. Le Burel, Laetitia Dunogeant, et al.. (2017). Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment. Annals of the Rheumatic Diseases. 76(10). 1747–1750. 165 indexed citations
16.
Collins, Michael, Jean‐Marie Michot, François‐Xavier Danlos, et al.. (2017). Gastrointestinal Immune Related Adverse Events Associated with Programmed-Death 1 Blockade. Gastroenterology. 152(5). S194–S194. 2 indexed citations
17.
18.
Michot, Jean‐Marie, Franck Carbonnel, Stéphane Champiat, et al.. (2017). Significance of Immune-related Lipase Increase Induced by Antiprogrammed Death-1 or Death Ligand-1 Antibodies: A Brief Communication. Journal of Immunotherapy. 41(2). 84–85. 34 indexed citations
19.
Michot, Jean‐Marie, Stéphane Champiat, Charlotte Mussini, et al.. (2017). P315 Gastrointestinal immune related adverse events associated with programmed-Death 1 blockade. Journal of Crohn s and Colitis. 11(suppl_1). S237–S237. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean Tayar Breakdown of academic impact, for papers by Mary Kate Kasler Breakdown of academic impact, for papers by B. Rovati Breakdown of academic impact, for papers by Konstantin Schlick Breakdown of academic impact, for papers by Benjamin C. Garden Breakdown of academic impact, for papers by Jessica Quarna Breakdown of academic impact, for papers by Anwar Giryes Breakdown of academic impact, for papers by Giovanna Motta Breakdown of academic impact, for papers by Gan‐di Li Breakdown of academic impact, for papers by Hassan El‐Solh
Rankless by CCL
2026